Seshadri S - Search Results

1

APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, Wen W, Høgh P, Raz N, Au R, Beiser A, Wolf PA, Romero JR, Zhu YC, Lunetta KL, Farrer L, Dufouil C, Kuller LH, Mazoyer B, Seshadri S, Tzourio C, Debette S. Schilling S, et al. Among authors: seshadri s. Neurology. 2013 Jul 16;81(3):292-300. doi: 10.1212/WNL.0b013e31829bfda4. Neurology. 2013. PMID: 23858411 Free PMC article. Review.

2

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.

Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB. Seshadri S, et al. Neurology. 1997 Dec;49(6):1498-504. doi: 10.1212/wnl.49.6.1498. Neurology. 1997. PMID: 9409336

3

Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Beiser A, et al. Among authors: seshadri s. Stat Med. 2000 Jun 15-30;19(11-12):1495-522. doi: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1495::aid-sim441>3.0.co;2-e. Stat Med. 2000. PMID: 10844714

4

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Seshadri S, et al. N Engl J Med. 2002 Feb 14;346(7):476-83. doi: 10.1056/NEJMoa011613. N Engl J Med. 2002. PMID: 11844848 Free article.

5

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA. Tan ZS, et al. Among authors: seshadri s. Arch Intern Med. 2003 May 12;163(9):1053-7. doi: 10.1001/archinte.163.9.1053. Arch Intern Med. 2003. PMID: 12742802

6

Homocysteine and the brain: vascular risk factor or neurotoxin?

Seshadri S, Wolf PA. Seshadri S, et al. Lancet Neurol. 2003 Jan;2(1):11. doi: 10.1016/s1474-4422(03)00258-8. Lancet Neurol. 2003. PMID: 12849292 No abstract available.

7

Framingham stroke risk profile and lowered cognitive performance.

Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Elias MF, et al. Among authors: seshadri s. Stroke. 2004 Feb;35(2):404-9. doi: 10.1161/01.STR.0000103141.82869.77. Epub 2004 Jan 15. Stroke. 2004. PMID: 14726556

8

Dementia after stroke: the Framingham Study.

Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Ivan CS, et al. Among authors: seshadri s. Stroke. 2004 Jun;35(6):1264-8. doi: 10.1161/01.STR.0000127810.92616.78. Epub 2004 Apr 29. Stroke. 2004. PMID: 15118167

9

Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Jeerakathil T, et al. Among authors: seshadri s. Stroke. 2004 Aug;35(8):1857-61. doi: 10.1161/01.STR.0000135226.53499.85. Epub 2004 Jun 24. Stroke. 2004. PMID: 15218158

10

New norms for a new generation: cognitive performance in the framingham offspring cohort.

Au R, Seshadri S, Wolf PA, Elias M, Elias P, Sullivan L, Beiser A, D'Agostino RB. Au R, et al. Among authors: seshadri s. Exp Aging Res. 2004 Oct-Dec;30(4):333-58. doi: 10.1080/03610730490484380. Exp Aging Res. 2004. PMID: 15371099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,139 results

Search Page

Filters